NL8301899A - Polyfluoralkanolen bevattend geneesmiddel. - Google Patents

Polyfluoralkanolen bevattend geneesmiddel. Download PDF

Info

Publication number: NL8301899A
Authority: NL; Netherlands
Prior art keywords: preparation according; pharmaceutical preparation; formula; parts; component
Prior art date: 1982-05-28

Application number

NL8301899A

Other languages

English (en)

Dutch (nl)

Original Assignee

Fcn Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-05-28

Filing date

1983-05-27

Publication date

1983-12-16

1983-05-27 Application filed by Fcn Srl filed Critical Fcn Srl

1983-12-16 Publication of NL8301899A publication Critical patent/NL8301899A/nl

Links

229940126601 medicinal product Drugs 0.000 title 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 18
239000000825 pharmaceutical preparation Substances 0.000 claims description 11
238000002360 preparation method Methods 0.000 claims description 10
235000012000 cholesterol Nutrition 0.000 claims description 9
KUGBQWBWWNPMIT-UHFFFAOYSA-N 1,1,2,2,3,3,4,4-octafluoropentan-1-ol Chemical compound CC(F)(F)C(F)(F)C(F)(F)C(O)(F)F KUGBQWBWWNPMIT-UHFFFAOYSA-N 0.000 claims description 7
239000008159 sesame oil Substances 0.000 claims description 6
235000011803 sesame oil Nutrition 0.000 claims description 6
230000000118 anti-neoplastic effect Effects 0.000 claims description 2
239000008194 pharmaceutical composition Substances 0.000 claims description 2
239000002904 solvent Substances 0.000 claims 2
239000013543 active substance Substances 0.000 claims 1
238000007911 parenteral administration Methods 0.000 claims 1
241001465754 Metazoa Species 0.000 description 8
239000000203 mixture Substances 0.000 description 6
241000699670 Mus sp. Species 0.000 description 5
206010028980 Neoplasm Diseases 0.000 description 5
241000700159 Rattus Species 0.000 description 4
230000001925 catabolic effect Effects 0.000 description 4
230000001195 anabolic effect Effects 0.000 description 3
230000000694 effects Effects 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
238000005303 weighing Methods 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000007059 acute toxicity Effects 0.000 description 2
231100000403 acute toxicity Toxicity 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
230000007665 chronic toxicity Effects 0.000 description 2
231100000160 chronic toxicity Toxicity 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
231100000915 pathological change Toxicity 0.000 description 2
230000036285 pathological change Effects 0.000 description 2
239000000243 solution Substances 0.000 description 2
231100000456 subacute toxicity Toxicity 0.000 description 2
238000010254 subcutaneous injection Methods 0.000 description 2
239000007929 subcutaneous injection Substances 0.000 description 2
GUAMVMSOIYAUSK-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-hexadecafluorononan-1-ol Chemical compound CC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(O)(F)F GUAMVMSOIYAUSK-UHFFFAOYSA-N 0.000 description 1
BYKNGMLDSIEFFG-UHFFFAOYSA-N 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptan-1-ol Chemical compound OCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)F BYKNGMLDSIEFFG-UHFFFAOYSA-N 0.000 description 1
208000005374 Poisoning Diseases 0.000 description 1
206010070863 Toxicity to various agents Diseases 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
-1 dodeca-fluorheptanol Chemical compound 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000035876 healing Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
231100000572 poisoning Toxicity 0.000 description 1
230000000607 poisoning effect Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/34—Halogenated alcohols
- C07C31/38—Halogenated alcohols containing only fluorine as halogen

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NL8301899A 1982-05-28 1983-05-27 Polyfluoralkanolen bevattend geneesmiddel. NL8301899A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2155382		1982-05-28
IT8221553A IT8221553A0 (it)	1982-05-28	1982-05-28	Composizioni farmaceutiche adattivita' antineoplastica.

Publications (1)

Publication Number	Publication Date
NL8301899A true NL8301899A (nl)	1983-12-16

Family

ID=11183507

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8301899A NL8301899A (nl)	1982-05-28	1983-05-27	Polyfluoralkanolen bevattend geneesmiddel.

Country Status (16)

Country	Link
JP (1)	JPS591414A (it)
AU (2)	AU552557B2 (it)
BE (1)	BE896838A (it)
CH (1)	CH653890A5 (it)
DE (1)	DE3319304A1 (it)
FR (1)	FR2527439A1 (it)
GB (1)	GB2121280B (it)
IE (1)	IE55137B1 (it)
IL (1)	IL68796A0 (it)
IN (1)	IN157042B (it)
IT (1)	IT8221553A0 (it)
LU (1)	LU84827A1 (it)
NL (1)	NL8301899A (it)
NZ (1)	NZ204393A (it)
SE (1)	SE8302976L (it)
ZA (1)	ZA833871B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3836971C1 (it) *	1988-10-31	1990-05-17	Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3219004C1 (de) *	1982-05-19	1984-03-01	Philippine Dr. 8000 München Hartmann	Arzneimittel zur Behandlung von Tumoren

1982
- 1982-05-28 IT IT8221553A patent/IT8221553A0/it unknown
1983
- 1983-05-20 CH CH2772/83A patent/CH653890A5/it not_active IP Right Cessation
- 1983-05-26 GB GB08314540A patent/GB2121280B/en not_active Expired
- 1983-05-26 JP JP58093889A patent/JPS591414A/ja active Pending
- 1983-05-26 AU AU15000/83A patent/AU552557B2/en not_active Expired - Fee Related
- 1983-05-26 BE BE2/60100A patent/BE896838A/nl not_active IP Right Cessation
- 1983-05-26 IL IL68796A patent/IL68796A0/xx unknown
- 1983-05-26 SE SE8302976A patent/SE8302976L/ not_active Application Discontinuation
- 1983-05-27 IN IN673/CAL/83A patent/IN157042B/en unknown
- 1983-05-27 IE IE1259/83A patent/IE55137B1/en unknown
- 1983-05-27 LU LU84827A patent/LU84827A1/fr unknown
- 1983-05-27 ZA ZA833871A patent/ZA833871B/xx unknown
- 1983-05-27 DE DE19833319304 patent/DE3319304A1/de not_active Ceased
- 1983-05-27 FR FR8308776A patent/FR2527439A1/fr not_active Withdrawn
- 1983-05-27 NL NL8301899A patent/NL8301899A/nl not_active Application Discontinuation
- 1983-05-27 NZ NZ204393A patent/NZ204393A/en unknown
1988
- 1988-05-04 AU AU15570/88A patent/AU1557088A/en not_active Abandoned

Also Published As

Publication number	Publication date
AU1557088A (en)	1988-11-10
ZA833871B (en)	1984-07-25
IN157042B (it)	1986-01-04
IE55137B1 (en)	1990-06-06
LU84827A1 (fr)	1983-11-17
BE896838A (nl)	1983-09-16
GB8314540D0 (en)	1983-06-29
FR2527439A1 (fr)	1983-12-02
GB2121280B (en)	1985-08-29
SE8302976D0 (sv)	1983-05-26
SE8302976L (sv)	1983-11-29
GB2121280A (en)	1983-12-21
IE831259L (en)	1983-11-28
AU552557B2 (en)	1986-06-05
IT8221553A0 (it)	1982-05-28
JPS591414A (ja)	1984-01-06
IL68796A0 (en)	1983-09-30
DE3319304A1 (de)	1983-12-01
CH653890A5 (it)	1986-01-31
NZ204393A (en)	1986-03-14
AU1500083A (en)	1983-12-01

Legal Events

Date	Code	Title	Description
1985-01-01	A85	Still pending on 85-01-01
1988-01-04	BV	The patent application has lapsed

Publication	Publication Date	Title
DE69233169T2 (de)	2004-05-27	Cisplatin und Topotecan enthaltende Zusammensetzung als antitumor.
US5929066A (en)	1999-07-27	Chromium/biotin treatment of Type II diabetes
EP1323423B1 (en)	2008-06-18	Combined preparation comprising a morpholinyl anthracycline derivative and a topoisomerase II inhibitor
CH686868A5 (de)	1996-07-31	Infusionsloesung fuer die Verabreichung von Taxol.
DE2710327B2 (de)	1980-04-17	Verwendung von Benzaldehyd
CA2297834C (en)	2008-09-30	Chromium/biotin treatment of type ii diabetes
DE69835824T2 (de)	2007-03-29	Antitumorkombination aus 3-amino-1,2,4-benzotriazine 1,4-dioxid/paclitaxel/platin
NL8301899A (nl)	1983-12-16	Polyfluoralkanolen bevattend geneesmiddel.
Rauth et al.	1978	Testing of hypoxic cell radiosensitizers in vivo
US4571335A (en)	1986-02-18	Method of inhibiting herpetic lesions by the use of platinum coordination compounds
DE19530708C2 (de)	1999-01-07	Pharmazeutisches Präparat mit trypanoziden Eigenschaften
JPS59205321A (ja)	1984-11-20	殺寄生虫性の協力的新規組合せ剤
DE2209526C3 (de)	1980-02-28	Coronartherapeutlkum in Form von Gelatine-BeiBkapseln
DE2314387C3 (de)	1980-10-02	Arzneimittel zur Behandlung bösartiger Neubildungen
US4873226A (en)	1989-10-10	Method of inhibiting herpetic lesions by the use of platinum coordination compounds
KR0147465B1 (ko)	1998-08-17	시스플라틴과 알로에신의 병용투여를 위한 항암요법 조성물
DE2320858A1 (de)	1973-11-08	Heilmittel fuer die behandlung von gestoertem blutkreislauf
DE60003189T2 (de)	2003-12-18	Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält
Kahán et al.	1975	The Parenteral Application of a New Metacycline Preparation, Tri-metacycline
JPS62236449A (ja)	1987-10-16	魚類餌料
EP0024202B1 (en)	1983-07-20	2,3,4,5,6-penta-o-acetyl-d-gluconyl isothiocyanate for use in preventing and treating cancer
AU2002302012B2 (en)	2005-02-10	Chromim/biotin treatment of type II diabetes
WO1999001432A1 (ru)	1999-01-14	Antidiabetes agent
JPH0386835A (ja)	1991-04-11	劇症肝炎治療剤
DE3224779A1 (de)	1984-01-12	Arzneimittel zur behandlung von tumoren